Marcus brings global M&A expertise, cross-border deal leadership, and investor-grade discipline to help ensure NDFC’s acquisitions are carried out with scale, precision, and transparency

Ryan’s experience in both PE & VC includes leading over 80 investments in seed stage companies and raising approximately $1B of outside capital post investment.

Bill is a veteran pharmaceutical executive with over 35 years of experience leading commercial strategy, business development, and growth across major pharmaceutical and contract manufacturing firms.

Paul is known for rigorous analysis, candid leadership, and fact-based execution delivering measurable results across multiple industries.